North America Breast Cancer Brachytherapy Market Size & Outlook

The breast cancer brachytherapy market in North America is expected to reach a projected revenue of US$ 49.8 million by 2027. A compound annual growth rate of 6% is expected of North America breast cancer brachytherapy market from 2019 to 2027.
Revenue, 2018 (US$M)
$29.6
Forecast, 2027 (US$M)
$49.8
CAGR, 2019 - 2027
6%
Report Coverage
North America

North America breast cancer brachytherapy market, 2015-2027 (US$M)

North

North America breast cancer brachytherapy market highlights

  • The North America breast cancer brachytherapy market generated a revenue of USD 29.6 million in 2018.
  • The market is expected to grow at a CAGR of 6% from 2019 to 2027.
  • In terms of segment, high dose rate (hdr) was the largest revenue generating technology in 2018.
  • High Dose Rate (HDR) is the most lucrative technology segment registering the fastest growth during the forecast period.
  • Country-wise, Canada is expected to register the highest CAGR from 2019 to 2027.

North America data book summary

Market revenue in 2018USD 29.6 million
Market revenue in 2027USD 49.8 million
Growth rate6% (CAGR from 2018 to 2027)
Largest segmentHigh dose rate (hdr)
Fastest growing segmentHigh Dose Rate (HDR)
Historical data covered2015 - 2017
Base year for estimation2018
Forecast period covered2019 - 2027
Quantitative unitsRevenue in USD million
Market segmentationHigh Dose Rate (HDR), Low Dose Rate (LDR)
Key market players worldwideEckert & Ziegler Bebig SA, Elekta AB ADR, Siemens Healthineers AG ADR, Icad Inc, Hologic Inc, Merit Medical Systems Inc

Other key industry trends

  • In terms of revenue, North America region accounted for 50.7% of the global breast cancer brachytherapy market in 2018.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2027.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 22.0 million by 2027.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Breast Cancer Brachytherapy Market Companies

Name Profile # Employees HQ Website

North America breast cancer brachytherapy market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to breast cancer brachytherapy market will help companies and investors design strategic landscapes.


High dose rate (hdr) was the largest segment with a revenue share of 66.22% in 2018. Horizon Databook has segmented the North America breast cancer brachytherapy market based on high dose rate (hdr), low dose rate (ldr) covering the revenue growth of each sub-segment from 2015 to 2027.


  • North America Breast Cancer Brachytherapy Technology Outlook (Revenue, USD Million, 2015-2027)
    • High Dose Rate (HDR)
    • Low Dose Rate (LDR)

Reasons to subscribe to North America breast cancer brachytherapy market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America breast cancer brachytherapy market databook

  • Our clientele includes a mix of breast cancer brachytherapy market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America breast cancer brachytherapy market, including forecasts for subscribers. This continent databook contains high-level insights into North America breast cancer brachytherapy market from 2015 to 2027, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

North America breast cancer brachytherapy market size, by country, 2015-2027 (US$M)

North America Breast Cancer Brachytherapy Market Share, 2018 & 2027 (US$M)

North America breast cancer brachytherapy market size, by country, 2015-2027 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more